Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Single-Arm, Open-Label, Multicenter Clinical Study to Evaluate the Efficacy and Safety of Arsenic Trioxide Combined With Chemotherapy in Patients With Relapsed SHH-Activated and/or TP53-Mutant Medulloblastoma

NCT07856069 is registered in ClinicalTrials.gov with Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University as lead sponsor.

NCT NCT07856069
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07856069 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Single-Arm, Open-Label, Multicenter Clinical Study to Evaluate the Efficacy and Safety of Arsenic Trioxide Combined With Chemotherapy in Patients With Relapsed SHH-Activated and/or TP53-Mutant Medulloblastoma
Lead sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase
Phase 2
Overall status
Not yet recruiting
Start date
October 31, 2026
Completion date
October 31, 2034
Enrollment
78 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

medulloblastoma